Skip to main navigation Skip to search Skip to main content

NN9536-4451 Effect and safety of semaglutide 2.4 mg once weekly on weight management in adolescents with overweight or obesity

Project: Research

Project Details

StatusActive
Effective start/end date09/9/19 → 12/31/26

Funding

  • Novo Nordisk Incorporated: $187,177.41